NIKKEI 225
29,408.17-255.33(-0.86%)HANG SENG
29,095.86-356.71(-1.21%)CRUDE OIL
60.99+0.35(+0.58%)
AstraZeneca PLC (AZN)
| Previous close | 48.09 |
| Open | 48.40 |
| Bid | 47.93 x 900 |
| Ask | 47.94 x 1300 |
| Day's range | 47.82 - 48.43 |
| 52-week range | 36.15 - 64.94 |
| Volume | 8,837,802 |
| Avg. volume | 12,239,766 |
| Market cap | 127.504B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 39.33 |
| EPS (TTM) | 1.22 |
| Earnings date | N/A |
| Forward dividend & yield | 1.40 (2.91%) |
| Ex-dividend date | 25 Feb 2021 |
| 1y target est | 62.35 |
- Zacks
The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, BioNTech, Moderna and AstraZeneca
The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, BioNTech, Moderna and AstraZeneca
- Motley Fool
FibroGen Inc (FGEN) Q4 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. Joining me on today's are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety, and Pharmacovigilance.
- Zacks
FDA Emergency Nod for J&J COVID-19 Vaccine Heats Up Competition
J&J's (JNJ) single shot COVID-19 vaccine gets FDA emergency use authorization. U.S. CDC Advisory Committee also recommends J&J's vaccine.
